These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 7473486
1. Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A. J Rheumatol; 1995 Aug; 22(8):1574-6. PubMed ID: 7473486 [Abstract] [Full Text] [Related]
2. [Methotrexate treatment in refractory juvenile rheumatoid arthritis]. Brik R. Harefuah; 1998 Dec 01; 135(11):509-11, 567. PubMed ID: 10911466 [Abstract] [Full Text] [Related]
3. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. Wallace CA, Sherry DD. J Rheumatol; 1992 Oct 01; 19(10):1604-7. PubMed ID: 1464876 [Abstract] [Full Text] [Related]
4. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. Foeldvari I, Wierk A. J Rheumatol; 2005 Feb 01; 32(2):362-5. PubMed ID: 15693100 [Abstract] [Full Text] [Related]
6. Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety. Huang JL. Br J Clin Pract; 1996 Sep 01; 50(6):311-4. PubMed ID: 8983319 [Abstract] [Full Text] [Related]
7. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN. J Rheumatol; 2004 Jan 01; 31(1):179-82. PubMed ID: 14705239 [Abstract] [Full Text] [Related]
8. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J. Arthritis Rheum; 2004 Apr 01; 50(4):1286-95. PubMed ID: 15077313 [Abstract] [Full Text] [Related]
9. Comparison of two schedules for administering oral low-dose methotrexate (weekly versus every-other-week) in patients with rheumatoid arthritis in remission: a twenty-four week, single blind, randomized study. Luis M, Pacheco-Tena C, Cazarín-Barrientos J, Lino-Pérez L, Goycochea MV, Vazquez-Mellado J, Burgos-Vargas R. Arthritis Rheum; 1999 Oct 01; 42(10):2160-5. PubMed ID: 10524688 [Abstract] [Full Text] [Related]
10. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. Ravelli A, Di Fuccia G, Molinaro M, Ramenghi B, Zonta L, Regazzi MB, Martini A. J Rheumatol; 1993 Sep 01; 20(9):1573-7. PubMed ID: 8164218 [Abstract] [Full Text] [Related]
11. Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Gottlieb BS, Keenan GF, Lu T, Ilowite NT. Pediatrics; 1997 Dec 01; 100(6):994-7. PubMed ID: 9374571 [Abstract] [Full Text] [Related]
12. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Albers HM, Wessels JA, van der Straaten RJ, Brinkman DM, Suijlekom-Smit LW, Kamphuis SS, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, Ten Cate R, Guchelaar HJ. Arthritis Rheum; 2009 Jan 15; 61(1):46-51. PubMed ID: 19116975 [Abstract] [Full Text] [Related]
13. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Bartoli M, Tarò M, Magni-Manzoni S, Pistorio A, Traverso F, Viola S, Magnani A, Gasparini C, Martini A, Ravelli A. Ann Rheum Dis; 2008 Mar 15; 67(3):370-4. PubMed ID: 17660217 [Abstract] [Full Text] [Related]
14. Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis. Felin EM, Prahalad S, Askew EW, Moyer-Mileur LJ. Arthritis Rheum; 2007 Mar 15; 56(3):984-94. PubMed ID: 17328076 [Abstract] [Full Text] [Related]
15. Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A. J Pediatr; 2013 Sep 15; 163(3):879-84. PubMed ID: 23664559 [Abstract] [Full Text] [Related]
17. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Pediatric Rheumatology International Trials Organization. Arthritis Rheum; 2004 Jul 15; 50(7):2191-201. PubMed ID: 15248217 [Abstract] [Full Text] [Related]
18. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Apaz MT, Baildam E, Fasth A, Gerloni V, Lahdenne P, Prieur AM, Ravelli A, Saurenmann RK, Gamir ML, Wulffraat N, Marodi L, Petty RE, Joos R, Zulian F, McCurdy D, Myones BL, Nagy K, Reuman P, Szer I, Travers S, Beutler A, Keenan G, Clark J, Visvanathan S, Fasanmade A, Raychaudhuri A, Mendelsohn A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organisation, Pediatric Rheumatology Collaborative Study Group. Arthritis Rheum; 2007 Sep 15; 56(9):3096-106. PubMed ID: 17763439 [Abstract] [Full Text] [Related]
19. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE, Bochkova AG, Bunchuk NV. Ter Arkh; 2008 Sep 15; 80(5):25-30. PubMed ID: 18590110 [Abstract] [Full Text] [Related]